Calidi Biotherapeutics Inc. Gains 62.39%
Tue, Apr 09, 2024 at 07:22 PM
Calidi Biotherapeutics Inc. (CLDI:NYSEMKT) shot up at $0.62, a gain of 62.4%. On Tue, Apr 09, 2024, CLDI:NYSEMKT touched a New 2-Week High of $0.62. The stock got featured on our News Catalysts scanner on Fri, Mar 15, 2024 at 05:27 PM in the 'EARNINGS' category. From Tue, Mar 26, 2024, the stock recorded 11.11% Up Days and 10.00% Green Days
The stock spiked on Tue, Apr 09, 2024 at $0.83 with a volume of 4M+.
About Calidi Biotherapeutics Inc. (CLDI:NYSEMKT)
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the price and yield performance of the FLAGLSX-Forensic Accounting Long-Short Index.
Top 10 Gainers:
- Scopus BioPharma Inc. (SCPS:NASDAQ), 212.5%
- Vinco Ventures Inc. (BBIG:NASDAQ), 200%
- Selina Hospitality PLC (SLNA:NASDAQ), 96.25%
- Laser Photonics Corporation (LASE:NASDAQ), 81.12%
- Mobile Global Esports Inc. (MGAM:NASDAQ), 77.78%
- two Class A (TWOA:NYSE), 71.47%
- Acrivon Therapeutics Inc. (ACRV:NASDAQ), 62.78%
- Calidi Biotherapeutics Inc. (CLDI:NYSEMKT), 62.39%
- Connexa Sports Technologies Inc. (CNXA:NASDAQ), 48.51%
- ICZOOM Group Inc. (IZM:NASDAQ), 43.45%